Healthcare conglomerate CVS Well being Company (NYSE: CVS) reported combined outcomes for the fourth quarter of 2024, with revenues rising modestly and earnings declining sharply.
December-quarter adjusted revenue plunged 44% year-over-year to $1.19 per share. On a reported foundation, web revenue was $1.62 billion or $1.30 per share in This autumn, in comparison with $2.05 billion or $1.58 per share within the prior-year quarter.
Revenues elevated 4% year-over-year to $97.7 billion within the fourth quarter. Whole same-store gross sales climbed 10.2% year-over-year.
“Our built-in mannequin permits us to uniquely ship a less complicated, related expertise that saves time, saves cash, and improves well being,” mentioned CVS CEO David Joyner.
